Cargando…

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors

Detalles Bibliográficos
Autores principales:	Gong, Jian, Nguyen, Van, Yin, Shen, Archer, Rich, Nguyen, Emely, Hutchins, Jeff, Freimark, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292426/ http://dx.doi.org/10.1186/2051-1426-2-S3-P206

Ejemplares similares

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
por: Gong, Jian, et al.
Publicado: (2013)

Antibody-mediated phosphatidylserine blockade significantly enhances the efficacy of downstream immune checkpoint inhibition in K1735 mouse melanoma
por: Huang, Xianming, et al.
Publicado: (2014)

Targeting phosphatidylserine synergizes with immune checkpoint blockade by inducing de novo tumor specific immunity
por: Huang, Xianming, et al.
Publicado: (2015)

Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771
por: Gray, Michael, et al.
Publicado: (2015)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers
por: Gray, Michael J., et al.
Publicado: (2016)

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
por: Belzile, Olivier, et al.
Publicado: (2018)

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
por: Khalil, Danny, et al.
Publicado: (2015)

Monoclonal antibody therapies targeting immune checkpoints induce fatal anaphylactic reactions in a murine model of breast cancer
por: Mall, Christine, et al.
Publicado: (2014)

Phosphatidylserine-targeting antibody induces M1 macrophage polarization, promotes myeloid derived suppressor cell differentiation and boosts tumor-specific immunity
por: Huang, Xianming, et al.
Publicado: (2013)

Novel monoclonal antibodies against pathogenic Leptospira
por: de Matos, Bruno Moisés, et al.
Publicado: (2014)

Technological and methodical process integration in manufacturing of monoclonal antibodies
por: Gronemeyer, Petra, et al.
Publicado: (2015)

FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy
por: Ring, Jennifer, et al.
Publicado: (2015)

Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
por: Natrah, MS, et al.
Publicado: (2012)

Rapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
por: Vega, Arantza, et al.
Publicado: (2014)

Identification of a novel immune checkpoint regulator and potential therapeutic antibody target in oncology
por: Sallee, Nathan, et al.
Publicado: (2015)

The effects of phosphatidylserine supplementation on cognitive functioning prior and following an acute bout of resistance training in young males
por: Parker, Adam, et al.
Publicado: (2010)

Soy-derived Phosphatidic Acid, Lysophosphatidic acid and Phosphatidylserine are sufficient to induce an increase in mTOR signaling
por: Gundermann, David M, et al.
Publicado: (2013)

The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities
por: Bjorck, Pia, et al.
Publicado: (2015)

Amelioration of joint inflammation by a PAR-2-specific monoclonal antibody
por: King, V, et al.
Publicado: (2005)

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

Partial characterization of two novel monoclonal antibodies for Listeria spp. Immunodetection
por: Moreira, Gustavo, et al.
Publicado: (2014)

Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin
por: Higaki, Jeffrey N, et al.
Publicado: (2015)

Developing an upstream process for a monoclonal antibody including medium optimization
por: Duvar, Sevim, et al.
Publicado: (2013)

Cell death and immune regulation: in vivo application of a novel agonistic monoclonal antibody for death receptor Fas
por: Yonehara, S
Publicado: (2003)

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients
por: Trivedi, Sumita, et al.
Publicado: (2015)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
por: Isaacs, JD, et al.
Publicado: (2005)

Monoclonal antibodies that recognize important functional elements of the HIV-1 integrase enzyme
por: Maroun, Richard G, et al.
Publicado: (2012)

Tumor kinetics prior to treatment correlate with response to checkpoint inhibitors
por: Cadena, Alexandra P, et al.
Publicado: (2015)

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
por: Patel, Mira, et al.
Publicado: (2015)

Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
por: Foy, Susan P, et al.
Publicado: (2013)

A monoclonal antibody against HIV Tat attenuates neurotoxicity via glutamate receptors
por: Rumbaugh, Jeffrey, et al.
Publicado: (2006)

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection
por: Chen, W, et al.
Publicado: (2009)

Development and implementation of a global Roche cell culture platform for production of monoclonal antibodies
por: Tröbs, Thomas, et al.
Publicado: (2013)

Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy
por: Makkouk, Amani, et al.
Publicado: (2015)

Scale-up considerations for monoclonal antibody production process: an oxygen transfer flux approach
por: Gimenez, Laura, et al.
Publicado: (2013)

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
por: Birge, R B, et al.
Publicado: (2016)

A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design
por: Chen, Y, et al.
Publicado: (2012)

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody
por: Boyerinas, Benjamin, et al.
Publicado: (2014)

Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF alpha monoclonal antibodies
por: Moshous, D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oculbb6va7ogfp08cunkmc349e